This statistic shows global revenues from top insulin-replacement medications in 2010. The medication Humalin brought in 0.78 billion euros in revenue worldwide.
Insulin-replacement medications - revenues 2010
Revenues from leading insulin-replacement medications in 2010
(in billion euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Revenue of top growing private specialty pharmacies in U.S. 2018
- Italy: number of biotech drugs marketed 2016-2017, by type
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by age
- Number of injection drugs that had shortages in Canada in 2013-2016, by company
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by gender
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Top drug classes prescribed to seniors living in LTC in Canada 2016, by rate of use
- Top drug classes prescribed to seniors living in LTC Canada 2016, by chronic use rate
- Price change of branded drugs U.S. 2011-2018
- Top drug classes prescribed to seniors in Canada 2016, by rate of use
- Biotech vs. Web 2.0 share of total U.S. venture investment 2005-2010
- Contributions share to R&D for transformative drugs of past 25 years as of 2016
- Pharma and biotech - average p/e ratios in 2005 and 2010
- Canadian biotechnology - number of companies 2012-2014
- U.S. insulin market distribution: leading companies 2011
Further related statistics
Evotec. (March 24, 2011). Revenues from leading insulin-replacement medications in 2010 (in billion euros) [Graph]. In Statista. Retrieved December 16, 2019, from https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec. "Revenues from leading insulin-replacement medications in 2010 (in billion euros)." Chart. March 24, 2011. Statista. Accessed December 16, 2019. https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec. (2011). Revenues from leading insulin-replacement medications in 2010 (in billion euros). Statista. Statista Inc.. Accessed: December 16, 2019. https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec. "Revenues from Leading Insulin-replacement Medications in 2010 (in Billion Euros)." Statista, Statista Inc., 24 Mar 2011, https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/
Evotec, Revenues from leading insulin-replacement medications in 2010 (in billion euros) Statista, https://www.statista.com/statistics/274506/revenues-from-insulin-replacement-medication/ (last visited December 16, 2019)